Up-regulation of FGF7 induced Intra-vesical Prostatic Protrusion of Benign Prostatic Hyperplasia via the ERK1/2 signaling pathway

Experimental Section: Research Article

Zhou Z. · Wu L. · Zhao S. · Xia S.-J. · Pan L. · Chen M. · Zhu Y.-P. · Jiang J.-T. · Shi F.

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details Abstract

Introduction: Intra-vesical Prostatic Protrusion (IPP) has been reported to be associated with bladder outlet obstruction (BOO) and is the main cause of LUTS during the development of Benign Prostatic Hyperplasia (BPH). However, the molecular mechanism of IPP is still unclear. Methods: Clinical data analysis was performed to detect the association of IPP and long-term complications in patients with BPH. To explore the molecular mechanism of IPP formation, we performed RNA sequencing on prostate tissues (IPP or not) Stromal cells obtained from IPP-derived primary cultures. Cell proliferation was evaluated by CCK-8 assay. Multiple proteins in the signaling pathway were assessed using western blot. Results: Firstly, we confirmed that IPP is a prognostic factor for long-term complications in patients with BPH. Then, Fibroblast growth factor 7 (FGF7) was up-regulated in IPP tissues compared to normal prostate tissues through RNA sequencing. We observed that FGF7 was up-regulated in both IPP tissues and IPP primary stromal cells through IHC, Western-blot and qRT-PCR. Meanwhile, FGF7 expression is significantly up-regulated in high IPP grade prostate tissues. Down-regulation of FGF7 in IPP-derived stromal cells led to impairment of proliferation and migration of the prostate epithelial cells via co-culture experiments. Additionally, FGF7 induced the epithelial-mesenchymal transition (EMT) process through binding to FGFR2. RNA sequencing analysis also revealed the activation of MAPK/ERK1/2 signaling pathway. Moreover, down-regulation of MAPK/ERK1/2 by specific inhibitor impacted effects of FGF7 stimulation in vitro. Conclusions: Our data revealed a novel amplification effect, namely stromal cells derived FGF7 promotes epithelial cell proliferation as well as stromal cell phenotype which eventually induced IPP formation. And targeting FGF7 significantly reduced epithelial to stromal transition, also providing a potential therapeutic target for BPH progression.

S. Karger AG, Basel

Article / Publication Details Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif